Sfoglia per AUTORE
GUIDA A
Collezione AOU Novara

  

Items : 8

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 May 20;41(15):2800-2814. doi: 10.1200/JCO.22.01667. Epub 2023 Jan 31.

2023
AO Alessandria
AOU Novara

Cortellini A; Pinato DJ; Saura C; Lyman GH; Kuderer NM; Grisanti S; Rossi M; Zoratto F; Generali D; Libertini M; Parisi A; Aujayeb A; Prat A; Diamantis N; Mukherjee U; Mazzoni F; Filetti M; Tondini C; Zambelli A; Berardi R; Guida A; Sanchez de Torre A; Iglesias M; Pimentel I; Rossi S; Rizzo G; Sinclair A; Lee AJX; Bertuzzi A; et alii...

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Jul 11;114(7):979-987. doi: 10.1093/jnci/djac057.

2022
AO Alessandria
AOU Novara

Ruiz-Camps I; Pinato DJ; Bower M; Diamantis N; Sinclair A; Colomba E; Tondini C; Maconi A; Betti M; Zambelli A; Guida A; Giusti R; Zoratto F; Queirolo P; Parisi A; Lambertini M; Tagliamento M; Mazzoni F; Tucci M; Berardi R; Generali D; Grisanti S; Provenzano S; Vincenzi B; Libertini M; Sanchez de Torre A; Rimassa L; Rossi S; Harbeck N; et alii...

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Russo A; Russano M; Tiseo M; Porzio G; Ficorella C; Addeo A; Friedlaender A; Banna GL; Passiglia F; Spinelli GP; Metro G; Migliorino MR; Zoratto F; Ricciardi S; Mansueto G; Pecci F; Di Marino P; Gori S; De Tursi M; Tuzi A; Della Gravara L; Rastelli F; Macerelli M; Gelibter A; Chiari R; Marchetti P; Antonuzzo L; Mazzoni F; Genova C; et alii...

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. in JAMA oncology / JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.

2022
AOU Novara

Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 Nov 2;13:17588359211053416. doi: 10.1177/17588359211053416. eCollection 202

2021
AO Alessandria
AOU Novara

Salazar R; Chopra N; Romeo M; Viansone A; Fotia V; Krengli M; Delany MB; Ruiz I; Newsom-Davis T; Porzio G; Del Mastro L; Bertuzzi A; Ciruelos EM; Pla H; Prat A; Strina C; Marin M; Van Hemelrijck M; Mukherjee U; Galazi M; Colomba-Blameble E; Chiudinelli L; Saggia C; Matas M; Aguilar Company J; Sharkey R; Loizidou A; Wuerstlein R; Berardi R; et alii...

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer. in Urologic oncology / Urol Oncol. 2017 Sep;35(9):541.e7-541.e13. doi: 10.1016/j.urolonc.2017.05.007. Epub 2017 May 29.

2017
AOU Novara

Iacovelli R; Cossu Rocca M; Galli L; De Giorgi U; Sabbatini R; Santoni M; Mosca A; Fornarini G; Massari F; Masini C; Bersanelli M; Biasco E; Lolli C; Guida A; Berardi R; Terrone C; Pastorino A; Ardizzoni A; Pinto C; Buti S; Nolè F; Tortora G;